OZO. V. Zaytseva

O. V. Zaytseva

*This is an algorithmically generated author record based on publicly available information.

O. V. Zaytseva has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Protocol for developing an Open Base of gRAduated EEG Signals (OBRAS)

    by A. A. Ivanov, D. V. Blinov, K. V. Voronkova, A. S. Petrukhin, O. V. Zaytseva, M. O. Abramov

    Background . Artificial intelligence (AI) systems based on neural networks enabling the automatic analysis of electroencephalography (EEG) examinations, such as detecting episodes of paroxysmal activity are currently being actively developed. Large datasets are required for training neural network algorithms. Objective : To develop a roadmap for the Open Base of Graduated EEG Signals (OBRAS) project, designed to eliminate the shortage of high-quality, annotated EEG recordings suitable for developing and training AI algorithms, as well as for creating educational programs and digital EEG atlases. Material and methods . The project protocol was drafted, which includes the collection of native EEG signals from open sources and from clinical practice of the participants, their deidentification and structured mapping. A two-tier data organization system was proposed: i) primary grouping into folders (e.g., Normal, Epi, NonEpi) and ii) main, flexible classification using a system of tags for age, sex, examination type, pathology, presence of specific EEG patterns, etc. Eligibility criteria and technical requirements for the recordings (format, number of channels, sampling frequency) were defined. Conclusion . The OBRAS project roadmap outlines the protocol, logical sequence of work, annotation methodology, funding model (non-profit partnership), and solutions in the areas of ethics and information security. The creation of such publicly accessible database will accelerate development of AI algorithms for automated EEG analysis. Implementation of the OBRAS project may significantly contribute to developing medical, research, and information technologies in neurophysiology.


  • The role of the phenosanic acid in the combined treatment of patients with epilepsy

    by K.V. Voronkova, A.M. Alieva, I.G. Nikitin, G.M. Musina, E.V. Surskaya, O.S. Zaitseva, N.G. Mashkevich, L.V. Gomonova, A.S. Petrukhin

    Epilepsy is one of the most studied chronic neurological disorders in the world. Despite significant progress in epilepsy research, some patients continue to experience recurrent seizures. It has been proven that oxidative stress plays an important role in epilepsy. Targeting oxidative stress may provide a novel therapeutic intervention to attenuate epileptogenesis as well as cognitive and psychiatric impairment in patients with epilepsy. One of the promising directions in the search for new strategies for the treatment of epilepsy is the combined use of antiepileptic drugs with antioxidants that affect the pathogenetic links of this disease. The new Russian antiepileptic drug fenosanoic acid (Dibufelon) has an anticonvulsant effect due to the inhibition of lipid peroxidation of brain cells and the reconstruction of cell membranes. This mechanism of action also paves the way for an increase in the effectiveness of co-administered drugs with phenosanoic acid. The effect of the drug on the cognitive and mental functions of patients, the regression of asthenia phenomena is also observed. The clinical efficacy and safety of the combination of this drug with other antiepileptic drugs in epilepsy has been demonstrated in experimental and clinical studies.